Back to search
Kaposiform Hemangioendothelioma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Kaposiform Hemangioendothelioma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Kaposiform Hemangioendothelioma trials you may qualify forLymphatic anomalies are a rare subset of vascular anomalies that are poorly understood. the understanding of the natural history, long-term outcomes, risk facto…
To research and explore the antibody protection and immune memory after vaccination in children with KHE during sirolimus administration. To explore the feasibi…
The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest pro…
The aim of this study was to evaluate the efficacy and safety of topical application of tacrolimus at different concentrations for superficial Kaposiform hemang…
The purpose of this study is to determine if the use of sirolimus in the treatment of children and young adults with complicated vascular anomalies will prove t…
Sirolimus has demonstrated efficacy in the treatment of kaposiform hemangioendothelioma (KHE); however, a high rate of rebound growth following discontinuation…
The purpose of this study is to compare the efficacy and safety of different concentration gradients of sirolimus in the treatment of Kaposiform hemangioendothe…